Cucurbitacins: Bioactivities and synergistic effect with small-molecule drugs
نویسندگان
چکیده
منابع مشابه
An integrated platform of genomic assays reveals small-molecule bioactivities.
Bioactive compounds are widely used to modulate protein function and can serve as important leads for drug development. Identifying the in vivo targets of these compounds remains a challenge. Using yeast, we integrated three genome-wide gene-dosage assays to measure the effect of small molecules in vivo. A single TAG microarray was used to resolve the fitness of strains derived from pools of (i...
متن کاملConjugates of Small Molecule Drugs with Antibodies and Other Proteins
Conjugates of small molecule drugs with antibodies (ADCs) and with other proteins (protein-drug conjugates, PDC) are used as a new class of targeted therapeutics combining the specificity of monoclonal antibodies (mAbs) and other proteins with potent cytotoxic activity of small molecule drugs for the treatment of cancer and other diseases. A(P)DCs have three major components, antibody (targetin...
متن کاملMining small-molecule screens to repurpose drugs
Repurposing and repositioning drugs--discovering new uses for existing and experimental medicines-is an attractive strategy for rescuing stalled pharmaceutical projects, finding treatments for neglected diseases, and reducing the time, cost and risk of drug development. As this strategy emerged, academic researchers began performing high-throughput screens (HTS) of small molecules--the type of ...
متن کاملStudies on the antitumor effect of cucurbitacins.
The carcinostatic activity of elatericin A, elatericin B, elaterin, elaterin methylether, dihydroelatericin A, and tetrahydroelatericin A, all cucurbitacins of a triterpene structure, and of trans-4-hydroxy-4-methylpent-~-enoic acid, the isolated side chain of the cucurbitacin molecule, was studied. Three cucurbitacins, elatericin A, elatericin B, and elaterin produced a moderate inhibition of ...
متن کاملSynergistic effect of \'Y-interferon and chemotherapeutic drugs on KE-37
Therapeutic use of biological response modulators in combination with chemotherapeutic drugs may propose a more efficient way for cancer therapy with fewer side effects. However, the related mechanism has not been well understood. Γ-interferon is a modulator of biological responses that inhibits the growth of malignant cells and mediates their differentiation. In this investigation, T cell lymp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Functional Foods
سال: 2020
ISSN: 1756-4646
DOI: 10.1016/j.jff.2020.104042